PMO Interview with the Innovator Series: Volume 1

Video Categories: PMO Interview with the Innovator Series

Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.

Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, Inc.
July 13, 2021

Occurrence of TRK Fusion–Positive Tumors in Different Cancer Types

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, confer on the categorization of various cancer types in which NTRK gene fusions may be detected.

October 8, 2014

Importance of Cytoreductive Therapy

Laura C. Michaelis, MD, Medical College of Wisconsin describes why cytoreductive therapy is important to discuss with patients with polycthemia vera.Supported through funding from Incyte